The Chrysalis Initiative's Breast Cancer Panel Series: The Tea On Testing

The Chrysalis Initiative's Breast Cancer Panel Series: The Tea On Testing

The featured experts spoke about how molecular imaging is playing a larger role in the earlier diagnosis, staging, and treatment-related evaluation and management of breast cancer for patients, as well as how diagnostic imaging may ultimately be instructive in determining the most appropriate course of treatment. Panelists shared strategies on how patients can become more effective in advocating for these imaging agents, as well as featured many of TCI’s resources, including the availability of coaches to help patients navigate throughout their journey.

The goals for this session were to amplify HCP and patient advocate awareness, education, and utilization of molecular imaging. Patients shared their stories and experiences and how TCI has helped them to become empowered partners in the diagnosis and management of their breast cancer and what that means in their day-to-day lives. The panel discussed patient profile - ER+ Recurrent or MBC patient types including indolent types such as ER+ invasive lobular cancer and de novo MBC; ER+ patients whose cancer spread mainly to the bone or other places difficult to biopsy (e.g., brain); ER+ patient with progression i.e., whose cancer has become worse or spread while on endocrine treatment.

Website: https://thechrysalisinitiative.org/
Donate: https://thechrysalisinitiative.org/do...
Instagram:   / chrysalisinitiative  
Facebook:   / chrysalisinitiative  
Twitter:   / chrysalisinit  
LinkedIn:   / admin